Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...

Gilead Sciences chairman and CEO Daniel O’Day joins 'Squawk Box' to discuss the FDA approval of the company's HIV prevention ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

As Congress finalizes a sweeping new federal spending bill, healthcare providers are sounding the alarm over what could be at ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to diagnose and treat HIV.

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

In a song out during Pride month and ahead of HIV testing day on June 27, a Nashville country singer discusses his own ...

OTTAWA COUNTY, MI – The Ottawa County Department of Public Health is offering free HIV and syphilis testing in Holland on ...